Th-17 Alloimmune Responses in Renal Allograft Biopsies from Recipients of Kidney Transplants Using Extended Criteria Donors during Acute T Cell-Mediated Rejection

American Journal of Transplantation

Volumn 15, Issue 10, 2015, Pages 2718-2725

  Matignon, M ^a,b   Aissat, A ^b   Canoui Poitrine, F ^a,b   Grondin, C ^a,b   Pilon, C ^a,b   Desvaux, D ^a,b   Saadoun, D ^c,d   Barathon, Q ^a,b   Garrido, M ^d   Audard, V ^a,b   Remy P ^a,b   Lang, P ^a,b   Cohen, J ^a,b   Grimbert, P ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Sorbonne Université   (France)

Author keywords

Biomarker; donors and donation: extended criteria; molecular biology: mRNA mRNA expression; rejection: T cell mediated (TCMR)

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CORTICOSTEROID; FC RECEPTOR; GAMMA INTERFERON; GENOMIC DNA; GRANZYME B; HLA ANTIBODY; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; PERFORIN; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ACUTE T CELL MEDIATED REJECTION; ADULT; AGED; ALLOIMMUNITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GERIATRIC PATIENT; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TH17 CELL; TREATMENT FAILURE; AGE; ALLOGRAFT; ALLOTRANSPLANTATION; BIOPSY; DONOR SELECTION; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLOGRAFTS; BIOMARKERS; BIOPSY; DONOR SELECTION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; INTERLEUKIN-17; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH17 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84941934422     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13304     Document Type: Article

References (30)

1. Wolfe RA, Roys EC, Merion RM,. Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 961-972.
2. Port FK, Bragg-Gresham JL, Metzger RA, et al., Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286.
3. Gill J, Bunnapradist S, Danovitch GM, Gjertson D, Gill JS, Cecka M,. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 2008; 52: 541-552.
4. Audard V, Matignon M, Dahan K, Lang P, Grimbert P,. Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview. Transpl Int 2008; 21: 11-17.
5. de Fijter JW, Mallat MJ, Doxiadis II, et al., Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538-1546.
6. Frei U, Noeldeke J, Machold-Fabrizii V, et al., Prospective age-matching in elderly kidney transplant recipients-a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57.
7. Tullius SG, Milford E,. Kidney allocation and the aging immune response. N Engl J Med 2011; 364: 1369-1370.
8. Pratschke J, Merk V, Reutzel-Selke A, et al., Potent early immune response after kidney transplantation in patients of the European senior transplant program. Transplantation 2009; 87: 992-1000.
9. Pascher A, Reutzel-Selke A, Jurisch A, et al., Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 2003; 76: 1560-1568.
10. Heinbokel T, Hock K, Liu G, Edtinger K, Elkhal A, Tullius SG,. Impact of immunosenescence on transplant outcome. Transpl Int 2013; 26: 242-253.
11. Haas M, Sis B, Racusen LC, et al., Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14: 272-283.
12. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al., A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133-3144.
13. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al., The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 1911-1920.
14. Sullivan JA, Adams AB, Burlingham WJ,. The emerging role of TH17 cells in organ transplantation. Transplantation 2014; 97: 483-489.
15. Strehlau J, Pavlakis M, Lipman M, et al., Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
16. Loverre A, Tataranni T, Castellano G, et al., IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant 2011; 11: 1248-1259.
17. Atalar K, Afzali B, Lord G, Lombardi G,. Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transplant 2009; 14: 23-29.
18. Yapici Ü, Kers J, Bemelman FJ, et al., Interleukin-17 positive cells accumulate in renal allografts during acute rejection and are independent predictors of worse graft outcome. Transpl Int 2011; 24: 1008-1017.
19. Tesar BM, Du W, Shirali AC, Walker WE, Shen H, Goldstein DR,. Aging augments IL-17 T-cell alloimmune responses. Am J Transplant 2009; 9: 54-63.
20. Melk A, Schmidt BM, Braun H, et al., Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 2009; 9: 114-123.
21. Gomez CR, Boehmer ED, Kovacs EJ,. The aging innate immune system. Curr Opin Immunol 2005; 17: 457-462.
22. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY,. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002; 197: 322-332.
23. Edozie FC, Nova-Lamperti EA, Povoleri GA, et al., Regulatory T-cell therapy in the induction of transplant tolerance: The issue of subpopulations. Transplantation 2014; 98: 370-379.
24. Zuber J, Grimbert P, Blancho G, et al., Prognostic significance of graft Foxp3 expression in renal transplant recipients: A critical review and attempt to reconcile discrepancies. Nephrol Dial Transplant 2013; 28: 1100-1111.
25. Muthukumar T, Dadhania D, Ding R, et al., Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342-2351.
26. Itoh S, Kimura N, Axtell RC, et al., Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 2011; 124: S187-S196.
27. Fan L, Benson HL, Vittal R, et al., Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 2011; 11: 911-922.
28. Deteix C, Attuil-Audenis V, Duthey A, et al., Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184: 5344-5351.
29. Vanaudenaerde BM, Meyts I, Vos R, et al., A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008; 32: 832-843.
30. Genovese MC, Greenwald M, Cho CS, et al., A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors. Arthritis Rheumatol 2014; 66: 1693-1704.